Jump to content

User contributions for JDoerfler

Results for JDoerfler talk block log uploads logs

A user with 1,085 edits. Account created on 25 January 2024.

14:3114:31, 26 September 2024 diff hist +74 Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial No edit summary
14:1814:18, 26 September 2024 diff hist +50 Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial No edit summary
14:0214:02, 26 September 2024 diff hist +1 Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial No edit summary
14:0114:01, 26 September 2024 diff hist +436 Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial No edit summary
13:2313:23, 26 September 2024 diff hist −41 Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial No edit summary
13:2113:21, 26 September 2024 diff hist +143 Homeopathy vs Nausea No edit summary

10:1510:15, 6 September 2024 diff hist +9,479 N Okabayashi et al. (2020): L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients Created page with "{{Reference |Reference=Publication: L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients }} {{Study Note}} =Brief summary= In this study, patients who had their liver removed due to liver cancer or biliary tract disease were included. The patients were randomly divided into 2 groups, with one group receiving carnitine for 2 weeks, while the other group received no additional intervention. After the surgery, a slightly shorter hospital stay was obs..."
09:3809:38, 6 September 2024 diff hist +1,931 N Publication: L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients Created page with "{{Publication |Title=L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients; Journal |Topic=Carnitine |Author=Okabayashi T; Sui K; Mastumoto T; Iwata J; Morita S; Iiyama T; Shimada Y |Year=2020 |Journal=Journal of parenteral and enteral nutrition |DOI=https://doi.org/10.1002/jpen.1720 |Authors Abstract=Background and aims: The effect of perioperative treatment with L-carnitine in hepatectomized patients is unclear. The objectiveof the current study..."
09:2209:22, 6 September 2024 diff hist −6 Hershman et al. (2018): Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine No edit summary current
09:2209:22, 6 September 2024 diff hist −24 Hershman et al. (2018): Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine No edit summary
09:2009:20, 6 September 2024 diff hist +119 Hershman et al. (2018): Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine No edit summary
09:1409:14, 6 September 2024 diff hist +1 Hershman et al. (2018): Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine No edit summary
09:1309:13, 6 September 2024 diff hist +737 Hershman et al. (2018): Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine No edit summary
09:0909:09, 6 September 2024 diff hist +4,575 Hershman et al. (2018): Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine No edit summary
08:2108:21, 6 September 2024 diff hist +2,179 Hershman et al. (2018): Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine No edit summary
08:1408:14, 6 September 2024 diff hist +419 Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy No edit summary
08:1308:13, 6 September 2024 diff hist +4 Hershman et al. (2018): Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine No edit summary
08:1208:12, 6 September 2024 diff hist +4,028 N Hershman et al. (2018): Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine Created page with "{{Reference |Reference=Publication: Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine }} {{Study Note}} =Brief summary= This study is a follow-up study of the 2013 study [Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy], in which the data of the patients are reported afte..."
08:1008:10, 6 September 2024 diff hist +2,411 N Publication: Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine Created page with "{{Publication |Title=Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine |Topic=Carnitine |Author=Hershman DL; Unger JM; Crew KD; Till C; Greenlee H; Minasian LM; Moinpour CM; Lew DL; Fehrenbacher L; Wade JL III; Wong SF; Fisch MJ; Henry NL; Albain KS |Year=2018 |Journal=Journal of the National Cancer |DOI=https://doi.org/10.1093/jnci/djx259 |Authors Abstract=Background: Chemotherapy-induced peripheral neuropathy (CI..."
07:3307:33, 6 September 2024 diff hist +1 Strasser et al. (2006): Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled (…) No edit summary
07:3207:32, 6 September 2024 diff hist +264 Strasser et al. (2006): Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled (…) No edit summary
07:2907:29, 6 September 2024 diff hist +113 Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial No edit summary
07:0107:01, 6 September 2024 diff hist +6 Lichtmann et al. (2018): Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain No edit summary
06:5106:51, 6 September 2024 diff hist +259 Johnson et al. (2010): Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain No edit summary

Retrieved from "https://camih.med.uni-jena.de/wiki/Special:Contributions/JDoerfler"